Affirm holdings director Quarles sells $1.39 million in stock

Affirm Holdings Director Christa S Quarles sold 15,000 Class A shares for $1.395 million on August 29, 2025, under a pre-arranged 10b5-1 plan, with InvestingPro noting the stock trades above fair value at a 521.23 P/E. This insider sale occurs amidst the company's strong Q4 fiscal 2025 performance, which saw revenue, adjusted EBIT, and gross merchandise volume significantly surpass analyst expectations. Following these robust results, several firms including Mizuho, UBS, and Stephens raised their price targets for Affirm, despite the recent director share divestment.

Analysis

Affirm Holdings, Inc. (AFRM) is exhibiting a clear divergence between robust operational performance and stretched valuation metrics. The company's fourth-quarter fiscal 2025 results significantly surpassed analyst expectations, with revenue growing 33% to $876 million and Gross Merchandise Volume expanding by 43%. This top-line strength was complemented by an adjusted EBIT of $237 million, comfortably beating the $204 million forecast. In response, multiple analysts, including those at Mizuho and RBC Capital, have raised their price targets, with Mizuho citing positive fiscal year 2026 guidance. However, this bullish fundamental picture is tempered by valuation concerns and insider activity. The stock, having surged 105% over the past year, is noted to be trading at a high P/E ratio of 521.23 and is considered above its fair value. Concurrently, a director sold 15,000 shares for $1.395 million. While this sale was executed under a pre-arranged Rule 10b5-1 plan, which mitigates its negative implication, it nonetheless represents profit-taking at these elevated levels.

Key Decisions for Investors

• Given the stock's 105% appreciation and a P/E ratio of 521.23, investors should be cautious of the stretched valuation and may consider trimming positions to realize gains, mirroring the director's pre-planned sale.
• Investors confident in management's ability to sustain high growth, as evidenced by the 43% GMV increase and strong FY26 guidance, could justify holding or adding to positions despite the premium valuation.
• Closely monitor upcoming quarters for continued outperformance in key metrics like GMV and adjusted EBIT to validate that the company's execution continues to support its elevated market price.